NRI scientist 
                                  makes AIDS breakthrough
                                 New York, January 18, 2006
                                  PTI
                                  
                                  'Friendly bacteria' found in yoghurt has been 
                                  genetically modified by a team of US researchers 
                                  headed by an Indian American to produce a drug 
                                  that blocks HIV infection.
                                Although the bacteria has only been tested 
                                  in a lab dish, scientists are optimistic the 
                                  technique could provide a cheaper and more effective 
                                  way of delivering drugs to fight the spread 
                                  of AIDS, by getting the bugs to live right where 
                                  the drugs are needed most, Nature magazine reported. 
                                
                                The bacterium (Lactococcus lactis) the researchers 
                                  have modified naturally produces lactic acid, 
                                  and so is used to produce cheese and yoghurt. 
                                  It is also found in some parts of the human 
                                  anatomy, including the gut and the vagina, where 
                                  the acid it produces damps down the growth of 
                                  other, harmful bacteria, Nature said. 
                                Some 'probiotic' yoghurts are loaded with such 
                                  beasties with the aim of keeping consumers' 
                                  guts healthy. Bharat Ramratnam, an HIV specialist 
                                  at Brown Medical School, Providence, Rhode Island, 
                                  and his colleagues have now altered the genetic 
                                  make-up of L.lactis so that it generates cyanovirin, 
                                  a drug that has prevented HIV infection in monkeys 
                                  and human cells, and is on track for human trials 
                                  in 2007, the magazine reported.
                                ANI adds: Cyanovirin binds to sugar molecules 
                                  attached to the HIV virus, blocking a receptor 
                                  that HIV uses to infect cells. 
                                "It's basically passive immunization," 
                                  says Sean Hanniffy, a molecular biologist at 
                                  the Institute of Food Research, Norwich, UK, 
                                  and part of the team.Gels containing cyanovirin 
                                  could afford some protection for women against 
                                  the transmission of HIV, but since the drug 
                                  breaks down quickly these would have to be used 
                                  just before sex. "In some countries there's 
                                  a reluctance to use these gels frequently," 
                                  explains Hanniffy.
                                Because lactic-acid bacteria live naturally 
                                  in the vagina, one application of a bacterial 
                                  goop should see the modified bugs thrive there 
                                  for at least a week, says Hanniffy. "The 
                                  next step might be to use other bacteria that 
                                  can survive for even longer," he adds.